Skip to main content
Clinical Trials/NCT05976516
NCT05976516RecruitingNot Applicable

Study on the Correlation Between CXCL2/CXCL8 and the Degree of Intervertebral Disc Degeneration and Radiological Progress

Zhongda Hospital1 site in 1 country40 target enrollmentStarted: August 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
CXCL2/8 content

Study Overview

Brief Summary

Low back pain (LBP) is the largest cause of morbidity in the world, and about 80% of Chinese people are affected in their lifetime. Although the prevalence of IDD gradually increases with age, IDD is very common among subjects under 30 years old. In addition to age, there are other factors, such as excessive or uneven mechanical load, obesity, genetics, nutrition, trauma and gender. In addition, it is not clear whether the heavy physical load associated with occupation is an important risk factor for IDD. Some studies have found that IDD is more common among athletes than the general population. Due to the complexity and multifactorial nature of IDD, its pathogenesis and risk factors are still unclear, which seriously hinders the rational stratification of LBP patients and limits the development of personalized treatment.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • It meets the diagnostic criteria of lumbar disc degeneration; No previous history of spinal surgery; Good ability of independent behavior and cooperation in completing research; The patient is aware of this study and has signed the consent form.

Exclusion Criteria

  • Patients with spinal tumor, infection, tuberculosis and other diseases; Patients with claustrophobia; Parkinson's syndrome patients; Poor cooperation, Poor image quality; Patients with osteoporosis.

Outcomes

Primary Outcomes

CXCL2/8 content

Time Frame: 1 month

CXCL2/CXCL8 content of nucleus pulposus

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Zhongda Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

pengfei, xue

Dr

Zhongda Hospital

Study Sites (1)

Loading locations...

Similar Trials

CXCL2/CXCL8 Promote Intervertebral Disc... | Clinical Trial